Hillary Davis, PA
Surgical · Alpine, UTNPI 1417546995
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $691 of the $789 with a category attached, or 87.6%. 8 manufacturers reported payments, led by Arcutis Biotherapeutics, Inc. at 31.9% of the total.
Across 14 payments — averaging $56.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arcutis Biotherapeutics, Inc.$252
- AbbVie$169
- Medical Device Business Services, Inc.$98
- Ambu Inc.$96
- UCB, Inc.$69
- Pfizer$61
- plus $44 from 2 others
What the payments were for
- Food & beverage$69188%
- Education$9812%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 2 | $252 |
| AbbVie | 3 | $169 |
| Medical Device Business Services, Inc. | 1 | $98 |
| Ambu Inc. | 1 | $96 |
| UCB, Inc. | 1 | $69 |
| Pfizer | 4 | $61 |
| Lilly USA, LLC | 1 | $26 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$125
How this compares
$789 in reported general payments places this provider in the 70th percentile of 121 surgical providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 34 | $155 |
| Finasteride | 16 | $81 |
Paid to pharmacies, not to this prescriber.
Other surgical in Alpine
- Scott HadfieldSalt Lake City$10K
- Brittany CrossSalt Lake City$6K
- Jason HoldenDraper$6K
- Stephen LoperAmerican Fork$5K
- Drew LambourneProvo$4K
- Brittney TaylorSalt Lake City$4K
- Richard ClowardOgden$4K
- David TranterDraper$3K
- Bradley BurtonAmerican Fork$3K
- Lindsay AdamsAmerican Fork$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.